Business Context and Reporting Period
Company: Viewbix Inc. (Note: Request metadata listed "Quantum X Labs Inc.", but the filing text identifies the registrant as Viewbix Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2024
Business Overview: Viewbix operates in digital advertising through two segments: the Search Segment (Gix Media), which automates and monetizes internet campaigns, and the Digital Content Segment (Cortex), which creates content to generate ad revenue. The company is a smaller reporting company and a non-accelerated filer.
Key Financial Metrics
| Metric (in thousands) | 9 Months Ended Sept 30, 2024 | 9 Months Ended Sept 30, 2023 | 3 Months Ended Sept 30, 2024 | 3 Months Ended Sept 30, 2023 |
|---|---|---|---|---|
| Revenues | $23,616 | $63,731 | $6,281 | $15,715 |
| Operating Loss | $(7,396) | $(1,478) | $(906) | $(1,652) |
| Net Loss | $(10,069) | $(2,209) | $(695) | $(1,781) |
| Net Loss Attributable to Shareholders | $(8,766) | $(2,031) | $(590) | $(1,510) |
| Cash and Cash Equivalents (Sept 30, 2024) | $1,405 | - | - | - |
| Total Debt (Short-term + Long-term) | $6,917 | $9,504 | - | - |
| Working Capital | $(4,037) | $(1,968) | - | - |
Note: All figures in thousands of U.S. dollars unless otherwise noted.
Material Changes vs. Prior Period
- Revenue Decline: Revenues dropped 63% year-over-year for the nine months ended September 30, 2024. The Digital Content segment fell 59% ($19.2M vs $47.1M) due to the "Cortex Adverse Effect" (loss of major advertisers due to "Made for Advertising" site restrictions). The Search segment fell 74% ($4.4M vs $16.6M) due to browser technology changes and reduced credit lines from partners.
- Goodwill Impairment: The company recorded a non-cash goodwill impairment charge of $4.74 million in the second quarter of 2024 related to the Digital Content segment, driven by reduced cash flow projections.
- Financial Expenses: Net financial expenses increased significantly to $2.76 million for the nine months ended September 30, 2024, compared to $0.69 million in the prior year. This includes a $2.52 million loss from the substantial modification of debt terms.
- Liquidity: Cash and cash equivalents decreased from $1.77 million (Dec 31, 2023) to $1.41 million (Sept 30, 2024). Working capital deficit widened to $4.04 million.
Guidance, Outlook, Risks, and Unusual Items
- Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern for the next 12 months due to revenue declines and accumulated deficits. Financial statements do not include adjustments that might be necessary if the company cannot continue.
- Capital Raising & Uplist: The company is pursuing an uplisting to the Nasdaq (application submitted Sept 13, 2024). Several credit facilities (June and July 2024 agreements) and a private placement ($0.26M gross proceeds) are contingent on this uplisting to unlock additional funding.
- Debt Restructuring: The company entered into multiple facility agreements in mid-2024 with high interest rates (12%) and significant equity kicker components (warrants and shares issued as interest). Repayment of certain bank loans has been deferred to late 2024/early 2025 subject to raising $2.0 million.
- Geopolitical Risk: Ongoing hostilities in Israel ("Iron Swords" War) have impacted operations through employee call-ups to military reserves, though the company received $0.34M in tax compensation.
- Reverse Stock Split: A 1-for-4 reverse stock split was approved but is not yet effective pending FINRA approval.
Investor Verification Checklist
- Uplist Status: Verify the current status of the Nasdaq uplisting application, as future funding tranches are contingent on this approval.
- Debt Covenants: Confirm compliance with the "positive EBITDA" covenant required by Bank Leumi and the ability to meet the $2.0 million funding requirement to extend credit facilities.
- Revenue Recovery: Assess whether the "Cortex Adverse Effect" is permanent or if new revenue streams have been successfully identified to replace lost advertiser spend.
- Dilution Risk: Review the terms of the June and July 2024 facility agreements, which involve significant issuance of shares and warrants (including a 21M share warrant) that could materially dilute existing shareholders.
- Cash Burn: Monitor the burn rate given the negative working capital of $4.04 million and the reliance on deferred loan repayments.